[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0587476T3 - Sammensætninger indeholdende mono- eller polyhydroxylerede aminosyrer til behandling af ikke-insulinkrævende diabetes melli - Google Patents

Sammensætninger indeholdende mono- eller polyhydroxylerede aminosyrer til behandling af ikke-insulinkrævende diabetes melli

Info

Publication number
DK0587476T3
DK0587476T3 DK93402135T DK93402135T DK0587476T3 DK 0587476 T3 DK0587476 T3 DK 0587476T3 DK 93402135 T DK93402135 T DK 93402135T DK 93402135 T DK93402135 T DK 93402135T DK 0587476 T3 DK0587476 T3 DK 0587476T3
Authority
DK
Denmark
Prior art keywords
insulin
treatment
amino acids
compositions containing
diabetes mellitus
Prior art date
Application number
DK93402135T
Other languages
English (en)
Inventor
Yves Sauvaire
Gerard Ribes
Gerard Residence Le Fran Ribes
Original Assignee
Jouvenet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jouvenet Soc Civ filed Critical Jouvenet Soc Civ
Application granted granted Critical
Publication of DK0587476T3 publication Critical patent/DK0587476T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK93402135T 1992-09-07 1993-09-01 Sammensætninger indeholdende mono- eller polyhydroxylerede aminosyrer til behandling af ikke-insulinkrævende diabetes melli DK0587476T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9210644A FR2695317B1 (fr) 1992-09-07 1992-09-07 Composition apte à stimuler la sécrétion d'insuline destinée au traitement du diabète non insulino-dépendant.

Publications (1)

Publication Number Publication Date
DK0587476T3 true DK0587476T3 (da) 1998-12-07

Family

ID=9433260

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93402135T DK0587476T3 (da) 1992-09-07 1993-09-01 Sammensætninger indeholdende mono- eller polyhydroxylerede aminosyrer til behandling af ikke-insulinkrævende diabetes melli

Country Status (9)

Country Link
US (1) US5470879A (da)
EP (1) EP0587476B1 (da)
JP (1) JP2655044B2 (da)
AT (1) ATE164064T1 (da)
CA (1) CA2105502C (da)
DE (1) DE69317494T2 (da)
DK (1) DK0587476T3 (da)
ES (1) ES2116421T3 (da)
FR (1) FR2695317B1 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2745718B1 (fr) * 1996-03-08 1998-05-07 Gestion Jouvenet Soc Civ De Composition antidiabetique a base de 4-hydroxyisoleucine
US6042834A (en) * 1997-01-29 2000-03-28 Baraka; Mohamed Wasif Herbal composition for diabetes and method of treatment
WO1998042340A1 (en) * 1997-03-24 1998-10-01 Galderma Research & Development, S.N.C. Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus
FR2797767B1 (fr) * 1999-08-27 2002-06-14 Centre Nat Rech Scient Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances
EP1255718A1 (en) 2000-02-01 2002-11-13 Stevia APS A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
US6329167B1 (en) * 2000-12-05 2001-12-11 Bruce K. Patterson Method of testing adequacy of cells in a specimen
WO2002050141A1 (en) * 2000-12-20 2002-06-27 Exxonmobil Chemical Patents Inc. Process for polymerizing cationically polymerizable monomers
US6551627B1 (en) * 2001-05-03 2003-04-22 Holomed Pharmaceuticals, Ltd. Medicinal herbal compounds for the prevention and treatment of diabetes
WO2003088947A1 (en) * 2002-04-22 2003-10-30 Experimental & Applied Sciences, Inc. Food supplements containing 4-hydroxyisoleucine and creatine
US20050176827A1 (en) * 2002-05-10 2005-08-11 Lee Steve S. Compositions and methods for glycogen synthesis
US7338675B2 (en) 2002-05-10 2008-03-04 Tsi Health Sciences, Inc. Fenugreek seed bio-active compositions and methods for extracting same
CN100415224C (zh) * 2003-03-18 2008-09-03 诺瓦提斯公司 包含脂肪酸和氨基酸的组合物
FR2852841B1 (fr) * 2003-03-28 2006-08-04 Vincience Composition cosmetique ou pharmaceutique comprenant des acides amines, utilisations et procedes de traitement
ATE390142T1 (de) * 2003-05-14 2008-04-15 Indus Biotech Pvt Ltd Synergistische zusammensetzung zur behandlung von diabetes mellitus
US7674486B2 (en) * 2003-05-14 2010-03-09 Indus Biotech Pvt. Ltd. Synergistic composition for the treatment of diabetes mellitus
US7736676B2 (en) * 2003-05-14 2010-06-15 Indus Biotech Pvt. Ltd. Synergistic composition for the treatment of diabetes mellitus
FR2856297B1 (fr) * 2003-06-18 2005-08-05 Caster Utilisation de (2s,3r,4s)-4-hydroxyisoleucine dans des compositions cosmetiques pour application topique
CN1313435C (zh) * 2003-10-27 2007-05-02 成都华高药业有限公司 一种从葫芦巴中提取4－羟基异亮氨酸制品的新方法
BRPI0415781A (pt) * 2003-10-27 2006-12-26 Innodia Inc método para o tratamento de diabetes em um paciente e kit farmacêutico
US20080182801A1 (en) * 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0513881D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
GB0329667D0 (en) * 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
US20050233014A1 (en) * 2004-03-02 2005-10-20 Lee Steve S Methods for affecting homeostasis and metabolism in a mammalian body
US7645466B2 (en) 2004-03-02 2010-01-12 Tsi Group Limited Methods for deriving, isolating, and/or extracting amino acid compositions from Fenugreek seed
US20050233013A1 (en) * 2004-03-02 2005-10-20 Lee Steve S Methods for enhancing the transport of glucose for balancing blood sugar levels
US20050226948A1 (en) * 2004-03-02 2005-10-13 Lee Steve S Methods for enhancing the transport of glucose into muscle
US20090076111A1 (en) * 2004-03-02 2009-03-19 Lee Steve S Methods for improving glycemic control in humans
JP2008530197A (ja) * 2005-02-18 2008-08-07 イノディア インク． ４−ヒドロキシイソロイシンの類似体及びその使用
US20060223884A1 (en) * 2005-03-22 2006-10-05 Nicolas Chapal Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
GB0512726D0 (en) * 2005-06-22 2005-07-27 Btg Int Ltd Multiple sclerosis therapy and diagnosis
FR2887773B1 (fr) * 2005-07-01 2008-05-30 Soc Extraction Principes Actif Utilisation d'un acide amine en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau.
GB0513888D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
US20100048545A1 (en) * 2006-03-22 2010-02-25 Innodia Inc. Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity
CA2678990A1 (en) * 2007-02-22 2008-08-28 Ajinomoto Co., Inc. Method for purifying 4-hydroxyisoleucine
RU2395580C2 (ru) 2007-12-21 2010-07-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) Способ конструирования бактерии-продуцента (2s,3r,4s)-4-гидрокси-l-изолейцина, бактерия-продуцент (2s,3r,4s)-4-гидрокси-l-изолейцина и способ продукции (2s,3r,4s)-гидрокси-l-изолейцина или его соли
AU2010283544B2 (en) 2009-08-12 2016-05-26 Munisekhar Medasani Natural Extract from Whole Banana Fruit (Musa Spp.)
WO2011021717A2 (en) 2009-08-21 2011-02-24 Ajinomoto Co.,Inc. Method for producing hydroxylated amino acids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2315916A2 (fr) * 1976-03-23 1977-01-28 Univ Johns Hopkins Melanges therapeutiques comprenant des analogues alpha hydroxy acides d'acides amines essentiels et leur administration a l'homme en vue de l'amelioration de la synthese proteique et la suppression de la formation d'uree
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids

Also Published As

Publication number Publication date
US5470879A (en) 1995-11-28
CA2105502C (fr) 2000-11-21
EP0587476A1 (fr) 1994-03-16
JPH06157302A (ja) 1994-06-03
CA2105502A1 (fr) 1994-03-08
EP0587476B1 (fr) 1998-03-18
DE69317494D1 (de) 1998-04-23
FR2695317B1 (fr) 1995-03-10
ATE164064T1 (de) 1998-04-15
DE69317494T2 (de) 1998-11-05
FR2695317A1 (fr) 1994-03-11
ES2116421T3 (es) 1998-07-16
JP2655044B2 (ja) 1997-09-17

Similar Documents

Publication Publication Date Title
DK0587476T3 (da) Sammensætninger indeholdende mono- eller polyhydroxylerede aminosyrer til behandling af ikke-insulinkrævende diabetes melli
MX9305054A (es) Usos novedosos de il-4 y/o il-10, y anticuerpos contra los mismos.
ATE153648T1 (de) Verwendungen von alpha-hydroxyfettsäuren
AR224323A1 (es) Composicion insecticida sinergizada que contiene crisantemato de n-(3,4,5,6-terahidroftalimido)-metilo o de 2-ali-3-metil-ciclopent-2-en-1-on-4-ilo y 3-fenoxibencil-2',2'-dimetil-3'-(2",2"-diclorovinil)-ciclopropanocarboxilato
HU9401633D0 (en) Fungicidal compositions
ATE148630T1 (de) Stabilisierte derivate von vitamin d2 und d3 enthaltende pharmazeutische zusammensetzungen
TR199802518T2 (xx) 4-Diketon ikameli yeni tiazolidon-2 t�revleri.
ES2102878T3 (es) Oxatiazinas conservantes de madera.
SE8404065D0 (sv) Novel biologically active compounds
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
DE59008356D1 (de) Heterocyclische Verbindungen.
DE60225143D1 (de) Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes
ATE315395T1 (de) Pharmazeutische zusammensetzungen, die faropenem natrium und eine diamineacetat verbindung zur verbesserung der magen-darm trakt absorption enthalten
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
SE8600658D0 (sv) Novel composition of matter
DE69104083D1 (de) Neue Antiulcus-Substanz.
EA199900881A1 (ru) Терапевтическое средство против сахарного диабета
MX170055B (es) , "composicion insecticida y procedimiento para su obtencion
ATE185946T1 (de) Insektenbekämpfungsverfahren und insektenbekämpfungsmittel
DE69015646D1 (de) Mittel zur anregung des haarwuchses.
DE69225306D1 (de) 1-Oleoylazacycloheptanon(2) enthaltende Arzneimittel zur Verstärkung des Transports durch biologische Membranen
RU93033611A (ru) Состав для борьбы с личинками подкожного овода крупного рогатого скота
TH12875EX (th) สารผสมต่อต้านปรสิตสำหรับใช้กับสัตว์
JPS5241237A (en) Herbicidal composition for use in paddy fields
MA19903A1 (fr) Sterilisation chimique d'insectes avec des salicylanilides.